Stocks News

LAST PRICE
45.7650
TODAY'S CHANGE (%)
Trending Down-0.0650 (-0.1418%)

Bid / Lots
45.6800/ 3
Ask / Lots
45.8500/ 8
Open / Previous Close
45.3300 / 45.8300
Day Range
Low 44.9100
High 45.9536
52 Week Range
Low 7.6000
High 59.2300
Volume
50,504
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 31, 2024
- Press Release: Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024, from 7:03AM ET on Thursday Oct 31, 2024 by Dow Jones
  7:03AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: HROW
  
  Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
  
  Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 14, 2024
- Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024, from 7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: HROW
  
  Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
  
  Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 14, 2024
Oct 17, 2024
- --B. Riley Adjusts Price Target on Harrow to $73 From $50, Maintains Buy Rating, from 12:48PM ET on Thursday Oct 17, 2024 by MT Newswires
  12:48PM ET on Thursday Oct 17, 2024 by MT Newswires
  Companies Mentioned: HROW
  12:48 PM EDT, 10/17/2024 (MT Newswires) -- Price: 56.01, Change: +1.19, Percent Change: +2.17 ...
Oct 10, 2024
- Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery, from 7:00AM ET on Thursday Oct 10, 2024 by Dow Jones
  7:00AM ET on Thursday Oct 10, 2024 by Dow Jones
  Companies Mentioned: HROW
  
  Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery

Yesterday
- Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: AVDL
Nov 1, 2024
- Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston, from 8:01AM ET on Friday Nov 01, 2024 by Dow Jones
  8:01AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: LGND
Oct 31, 2024
- DJ Avadel Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 4:06PM ET on Thursday Oct 31, 2024 by Dow Jones
  4:06PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: AVDL
- DJ Avadel Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 2:31PM ET on Thursday Oct 31, 2024 by Dow Jones
  2:31PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: AVDL
- DJ Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation, from 11:14AM ET on Thursday Oct 31, 2024 by Dow Jones
  11:14AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: AVDL, JAZZ
- DJ Ligand Pharmaceuticals Price Target Maintained With a $157.00/Share by HC Wainwright & Co., from 10:18AM ET on Thursday Oct 31, 2024 by Dow Jones
  10:18AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: LGND
- Wall Street Set to Open Lower Thursday; Inflation Data Meets Expectations, Initial Jobless Claims Decline, from 9:06AM ET on Thursday Oct 31, 2024 by MT Newswires
  9:06AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AVDL, JAZZ, MDJH, ATEC, EQ, CMPS, ROOT, RELY, TNON, MTNB, EL
- DJ Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham, from 8:26AM ET on Thursday Oct 31, 2024 by Dow Jones
  8:26AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: AVDL
- Investors Await Key Inflation, Employment Data as US Futures Move Lower in Thursday's Premarket, from 8:09AM ET on Thursday Oct 31, 2024 by MT Newswires
  8:09AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AVDL, MDJH, EQ, ROOT, TNON, MTNB
- Top Premarket Gainers, from 7:56AM ET on Thursday Oct 31, 2024 by MT Newswires
  7:56AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AVDL, BKNG, CVNA, ROOT

Harrow Inc
NASDAQ:HROWUnited States

Search Criteria

Oct 31, 2024

Press Release: Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024, from 7:03AM ET on Thursday Oct 31, 2024 by Dow Jones

Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024, from 7:00AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 17, 2024

--B. Riley Adjusts Price Target on Harrow to $73 From $50, Maintains Buy Rating, from 12:48PM ET on Thursday Oct 17, 2024 by MT Newswires

Oct 10, 2024

Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery, from 7:00AM ET on Thursday Oct 10, 2024 by Dow Jones

Peers Headlines

Yesterday

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones

Nov 1, 2024

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston, from 8:01AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

DJ Avadel Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 4:06PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Avadel Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 2:31PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation, from 11:14AM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Ligand Pharmaceuticals Price Target Maintained With a $157.00/Share by HC Wainwright & Co., from 10:18AM ET on Thursday Oct 31, 2024 by Dow Jones

Wall Street Set to Open Lower Thursday; Inflation Data Meets Expectations, Initial Jobless Claims Decline, from 9:06AM ET on Thursday Oct 31, 2024 by MT Newswires

DJ Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham, from 8:26AM ET on Thursday Oct 31, 2024 by Dow Jones

Investors Await Key Inflation, Employment Data as US Futures Move Lower in Thursday's Premarket, from 8:09AM ET on Thursday Oct 31, 2024 by MT Newswires

Top Premarket Gainers, from 7:56AM ET on Thursday Oct 31, 2024 by MT Newswires